Skip to main content

Instil Bio, Inc.

TIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001789769

No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, −5 vs. previous quarter
26
13F valueReported value at the end of Q2 2026
$30.0M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding TIL, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding TIL at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Instil Bio, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 12, 2025 (view filing)Sep 102 daysLaumas SandeepCFO and CBOSSale−30.0K$23.39−$701.7K−100.0%0 after2 lots

Top 10 13F holders, Q2 2026

The largest institutional positions in Instil Bio, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 26 holders
Institutions holding TIL in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Curative Ventures V LLC1,899,004$14.6M100.00%00.0%Unchanged
BML Capital Management, LLC645,600$4.96M2.84%00.0%Unchanged
Vivo Capital, LLC292,743$2.25M0.21%00.0%Unchanged
Kalehua Capital Management LLC199,200$1.53M0.49%−123,679−38.3%Reduced
UBS Group AG177,423$1.36M0.00%+171,045+2,681.8%Added
Vanguard Capital Management LLC163,738$1.26M0.00%−10,845−6.2%Reduced
Millennium Management LLC134,575$1.03M0.00%+1,629+1.2%Added
BlackRock, Inc.55,504$426.8K0.00%+3,486+6.7%Added
Renaissance Technologies LLC50,300$386.8K0.00%−8,800−14.9%Reduced
Nomura Asset Management International Inc.50,000$385.0K0.00%00.0%Unchanged